User menu

Anti-Glc(alpha 1,4)Glc(alpha) IgM antibodies for predict the development of relapsing-remitting multiple sclerosis after the first neurological event

Bibliographic reference Freedman, MS ; Sindic, Christian ; Dotan, N. ; Schwarz, Maik ; Weishaus, O ; et. al. Anti-Glc(alpha 1,4)Glc(alpha) IgM antibodies for predict the development of relapsing-remitting multiple sclerosis after the first neurological event.21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS (Thessaloniki (Greece), Sep 28-oct 01, 2005). In: Multiple Sclerosis : clinical and laboratory research, Vol. 11, p. S180-S181 (2005)
Permanent URL
  1. Munafo A., Trinchard-Lugan I., Nguyen T.X.Q., Buraglio M., Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration, 10.1046/j.1468-1331.1998.520187.x
  2. Witt Patricia L., Storer Barry E., Bryan George T., Brown Raymond R., Flashner M, Larocca Anne T., Colby C B, Borden E C, Pharmacodynamics of Biological Response In Vivo After Single and Multiple Doses of Interferon????? : , 10.1097/00002371-199304000-00006
  3. Khan O. A., Dhib-Jalbut S. S., Serum interferon  -1a (Avonex) levels following intramuscular injection in relapsing-remitting MS patients, 10.1212/wnl.51.3.738
  4. Evidence of interferon  -1a dose response in relapsing-remitting MS: The OWIMS Study, 10.1212/wnl.53.4.679
  5. Ebers George C, Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis, 10.1016/s0140-6736(98)03334-0
  6. Li David K. B., Paty Donald W., , Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-?1a in relapsing-remitting multiple sclerosis, 10.1002/1531-8249(199908)46:2<197::aid-ana9>;2-p
  7. PRISMS-4: Long-term efficacy of interferon- -1a in relapsing MS, 10.1212/wnl.56.12.1628
  8. , Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial, 10.1212/wnl.43.4.655
  9. Clanet M., Radue E.W., Kappos L., Hartung H.P., Hohlfeld R., Sandberg-Wollheim M., Kooijmans-Coutinho M.F., Tsao E.C., Sandrock A.W., A randomized, double-blind, dose-comparison study of weekly interferon  -1a in relapsing MS, 10.1212/01.wnl.0000032256.35561.d6
  10. Panitch H., Goodin D.S., Francis G., Chang P., Coyle P.K., O'Connor P., Monaghan E., Li D., Weinshenker B., Randomized, comparative study of interferon  -1a treatment regimens in MS: The EVIDENCE Trial, 10.1212/01.wnl.0000034080.43681.da
  11. Durelli Luca, Verdun Elisabetta, Barbero Pierangelo, Bergui Mauro, Versino Elisabetta, Ghezzi Angelo, Montanari Enrico, Zaffaroni Mauro, Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN), 10.1016/s0140-6736(02)08430-1
  12. Jacobs Lawrence D., Cookfair Diane L., Rudick Richard A., Herndon Robert M., Richert John R., Salazar Andres M., Fischer Jill S., Goodkin Donald E., Granger Carl V., Simon Jack H., Alam John J., Bartoszak David M., Bourdette Dennis N., Braiman Jonathan, Brownscheidle Carol M., Coats Michael E., Cohan Stanley L., Dougherty David S., Kinkel Revere P., Mass Michele K., Munschauer Frederick E., Priore Roger L., Pullicino Patrick M., Scherokman Barbara J., Weinstock-Guttman Bianca, Whitham Ruth H., , Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis, 10.1002/ana.410390304
  13. Biogen, I., Summary basis for approval (1995)
  14. Jacobs Lawrence D., Beck Roy W., Simon Jack H., Kinkel R. Phillip, Brownscheidle Carol M., Murray Thomas J., Simonian Nancy A., Slasor Peter J., Sandrock Alfred W., Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis, 10.1056/nejm200009283431301
  15. Comi Giancarlo, Filippi Massimo, Barkhof Frederik, Durelli Luca, Edan Gilles, Fernández Oscar, Hartung Hans-Peter, Seeldrayers Pierrette, Sørensen Per Soelberg, Rovaris Marco, Martinelli Vittorio, Hommes Otto R, Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study, 10.1016/s0140-6736(00)04725-5